Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma

Journal of Glaucoma

Volumn 20, Issue 2, 2011, Pages 100-108

  Colafrancesco, Valeria ^a   Parisi, Vincenzo ^a   Sposato, Valentina ^b   Rossi, Simona ^b   Russo, Matteo Antonio ^c   Coassin, Marco ^d   Lambiase, Alessandro ^d   Aloe, Luigi ^b  

^a IRCCS FONDAZIONE BIETTI   (Italy)

^b CNR   (Italy)

^c IRCCS SAN RAFFAELE PISANA   (Italy)

^d UNIVERSITY CAMPUS BIO MEDICO   (Italy)

Author keywords

Glaucoma (GL); intraocular pressure (IOP); neurotrophins; NGFreceptor; retinal ganglion cell (RGC)

Indexed keywords

NERVE GROWTH FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DISEASE MODEL; DRUG MECHANISM; GLAUCOMA; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RETINA DEGENERATION; RETINA GANGLION CELL;

ADMINISTRATION, TOPICAL; ANIMALS; BLOTTING, WESTERN; CELL COUNT; DISEASE MODELS, ANIMAL; GLAUCOMA; IMMUNOHISTOCHEMISTRY; INTRAOCULAR PRESSURE; MALE; NERVE DEGENERATION; NERVE GROWTH FACTOR; OPHTHALMIC SOLUTIONS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RETINAL DEGENERATION; RETINAL GANGLION CELLS; TONOMETRY, OCULAR;

EID: 79951675603     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: 10.1097/IJG.0b013e3181d787e5     Document Type: Article

References (44)

1. Quigley HA. Number ofpeople with glaucoma worldwide. Br J Ophthalmol. 1996;80:389-393.
2. Levin LA. Retinal ganglion cells and neuroprotection for glaucoma. Surv Ophthalmol. 2003;48(suppl 1):S21-S24. (Pubitemid 41126692)
3. Weinreb RN, Khaw PT. Primary open-angle glaucoma. Lancet. 2004;363:1711-1720. (Pubitemid 38670330)
4. Sommer A. Intraocular pressure and glaucoma. Am J Ophthalmol. 1989;107:186-188. (Pubitemid 19049847)
5. Kuehn MH, Fingert JH, Kwon YH. Retinal ganglion cell death in glaucoma: mechanisms and neuroprotective strategies. Ophthalmol Clin North Am. 2005;18:383-395, vi. (Pubitemid 41073864)
6. Guo L, Moss SE, Alexander RA, et al. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci. 2005;46:175-182. (Pubitemid 40041195)
7. Schwartz M. Lessons for glaucoma from other neurodegen-erative diseases: can one treatment suit them all? J Glaucoma. 2005;14:321-323. (Pubitemid 41023022)
8. Hartwick AT. Beyond intraocular pressure: neuroprotective strategies for future glaucoma therapy. Optom Vis Sci. 2001;78: 85-94. (Pubitemid 32199713)
9. Levi-Montalcini R. The nerve growth factor 35 years later. Science. 1987;237:1154-1162. (Pubitemid 17124912)
10. Connor B, Dragunow M. The role ofneuronal growth factors in neurodegenerative disorders of the human brain. Brain Res Brain Res Rev. 1998;27:1-39. (Pubitemid 28300281)
11. Aloe L, Calza L, eds. NGF and Related Molecules in Health and Disease. Amsterdam: Elsevier; 2004: 544.
12. Casaccia-Bonnefil P, Gu C, Chao MV. Neurotrophins in cell survival/death decisions. Adv Exp Med Biol. 1999;468: 275-282. (Pubitemid 32197936)
13. Meakin SO, Shooter EM. The nerve growth factor family of receptors. Trends Neurosci. 1992;15:323-331.
14. Carmignoto G, Maffei L, Candeo P, et al. Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section. J Neurosci. 1989;9:1263-1272. (Pubitemid 19116746)
15. Rabacchi SA, Ensini M, Bonfanti L, et al. Nerve growth factor reduces apoptosis of axotomized retinal ganglion cells in the neonatal rat. Neuroscience. 1994;63:969-973. (Pubitemid 24366148)
16. Siliprandi R, Canella R, Carmignoto G. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. Invest Ophthalmol Vis Sci. 1993;34: 3232-3245. (Pubitemid 23346655)
17. Lenzi L, Coassin M, Lambiase A, et al. Effect of exogenous administration of nerve growth factor in the retina of rats with inherited retinitis pigmentosa. Vision Res. 2005;45: 1491-1500. (Pubitemid 40386723)
18. LaVail MM, Unoki K, Yasumura D, et al. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects ofconstant light. Proc Natl Acad Sci USA. 1992;89:11249-11253.
19. Lambiase A, Centofanti M, Micera A, et al. Nerve growth factor (NGF) reduces and NGF antibody exacerbates retinal damage induced in rabbit by experimental ocular hypertension. Graefes Arch Clin Exp Ophthalmol. 1997;235:780-785. (Pubitemid 27514275)
20. Lambiase A, Aloe L. Nerve growth factor delays retinal degeneration in C3H mice. Graefes Arch Clin Exp Ophthalmol. 1996;234(suppl 1):S96-S100.
21. Mey J, Thanos S. Intravitreal injections of neurotrophic factors support the survival of axotomized retinal ganglion cells in adult rats in vivo. Brain Res. 1993;602:304-317. (Pubitemid 23053202)
22. Hallbook F, Backstrom A, Kullander K, et al. Expression of neurotrophins and trk receptors in the avian retina. J Comp Neurol. 1996;364:664-676. (Pubitemid 26046016)
23. Oku H, Ikeda T, Honma Y, et al. Gene expression of neurotrophins and their high-affinity Trk receptors in cultured human Muller cells. Ophthalmic Res. 2002;34:38-42. (Pubitemid 34136848)
24. Garca M, Forster V, Hicks D, et al. In vivo expression of neurotrophins and neurotrophin receptors is conserved in adult porcine retina in vitro. Invest Ophthalmol Vis Sci. 2003; 44:4532-4541. (Pubitemid 37186292)
25. Lambiase A, Tirassa P, Micera A, et al. Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats. Invest Ophthalmol Vis Sci. 2005;46: 3800-3806. (Pubitemid 44264689)
26. Lambiase A, Pagani L, Di Fausto V, et al. Nerve growth factor eye drop administrated on the ocular surface of rodents affects the nucleus basalis and septum: biochemical and structural evidence. Brain Res. 2007;1127:45-51. (Pubitemid 44873000)
27. Di Fausto V, Fiore M, Tirassa P, et al. Eye drop NGF administration promotes the recovery of chemically injured cholinergic neurons of adult mouse forebrain. Eur J Neurosci. 2007;26:2473-2480. (Pubitemid 350050448)
28. Morrison JC, Moore CG, Deppmeier LM, et al. A rat model of chronic pressure-induced optic nerve damage. Exp Eye Res. 1997;64:85-96. (Pubitemid 27096643)
29. Bocchini V, Angeletti PU. The nerve growth factor: purifica-tion as a 30,000-molecular-weight protein. Proc Natl Acad Sci USA. 1969;64:787-794.
30. Sun X, Jin K, Xie L, et al. Effects of nerve growth factor for retinal cell survival in experimental retinal detachment. Curr Eye Res. 2007;32:765-772. (Pubitemid 47450622)
31. Casaccia-Bonnefil P, Kong H, Chao MV. Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death Differ. 1998;5:357-364. (Pubitemid 28356811)
32. Salis MB, Graiani G, Desortes E, et al. Nerve growth factor supplementation reverses the impairment, induced by type 1 diabetes, of hindlimb post-ischaemic recovery in mice. Diabe-tologia. 2004;47:1055-1063. (Pubitemid 38918165)
33. Graiani G, Emanueli C, Desortes E, et al. Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of type 1 diabetic mice. Diabetologia. 2004;47:1047-1054. (Pubitemid 38918164)
34. Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthal-mol Vis Sci. 2000;41:1181-1185. (Pubitemid 30187558)
35. Koevary SB. Pharmacokinetics oftopical ocular drug delivery: potential uses for the treatment of diseases of the posterior segment and beyond. Curr Drug Metab. 2003;4:213-222. (Pubitemid 36656479)
36. Sposato V, Bucci MG, Coassin M, et al. Reduced NGF level and TrkA protein and TrkA gene expression in the optic nerve of rats with experimentally induced glaucoma. Neurosci Lett. 2008;446:20-24.
37. Sposato V, Parisi V, Manni L, et al. Glaucoma alters the expression of NGF and NGF receptors in visual cortex and geniculate nucleus of rats: effect of eye NGF application. Vision Res. 2009;49:54-63.
38. Coassin M, Lambiase A, Sposato V, et al. Retinal p75 and bax overexpression is associated with retinal ganglion cells apopto-sis in a rat model of glaucoma. Graefes Arch Clin Exp Ophthal-mol. 2008;246:1743-1749.
39. Lambiase A, Aloe L, Centofanti M, et al. Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops: implications for glaucoma. Proc Natl Acad Sci USA. 2009;109:13469-13474.
40. Rudzinski M, Wong TP, Saragovi HU. Changes in retinal expression of neurotrophins and neurotrophin receptors induced by ocular hypertension. J Neurobiol. 2004;58:341-354. (Pubitemid 38199123)
41. Shi Z, Birman E, Saragovi HU. Neurotrophic rationale in glau-coma: a TrkA agonist, but not NGF or a p75 antagonist, pro-tects retinal ganglion cells in vivo. Dev Neurobiol. 2007;67: 884-894. (Pubitemid 47066919)
42. WoldeMussie E, Ruiz G, Wijono M, et al. Neuroprotection of retinal ganglion cells by brimonidine in rats with laser-induced chronic ocular hypertension. Invest Ophthalmol Vis Sci. 2001;42: 2849-2855. (Pubitemid 33035282)
43. Bakalash S, Rolls A, Lider O, et al. Chondroitin sulfate-derived disaccharide protects retinal cells from elevated intra-ocular pressure in aged and immunocompromised rats. Invest Ophthalmol Vis Sci. 2007;48:1181-1190. (Pubitemid 351261413)
44. Hare W, WoldeMussie E, Lai R, et al. Efficacy and safety of memantine, an NMDA-type open-channel blocker, for reduction of retinal injury associated with experimental glaucoma in rat and monkey. Surv Ophthalmol. 2001;45(suppl 3):S284-S289.